Novartis' latest campaign for metastatic breast cancer drug Kisqali includes social media ads featuring the tri-color mBC ribbon. (via Shutterstock)

No­var­tis re­fresh­es Kisqali metasta­t­ic breast can­cer cam­paign with mes­sage to both ‘live longer and live well’

No­var­tis doesn’t think peo­ple liv­ing with metasta­t­ic breast can­cer should have to set­tle for ei­ther liv­ing longer or liv­ing well. Its re­cent­ly up­dat­ed Kisqali ad cam­paign de­liv­ers the mes­sage that pa­tients can have both.

“Why choose be­tween a longer life and qual­i­ty of life? You de­serve both,” the nar­ra­tor says in its lat­est TV com­mer­cial.

“Un­der­stand­ing the pa­tient ex­pe­ri­ence and rec­og­niz­ing a point of ten­sion those liv­ing with mBC of­ten face, our ‘Long Live Well’ cam­paign aims to high­light that peo­ple liv­ing with mBC don’t have to set­tle,” a No­var­tis spokesper­son said via email. “We strived to re­flect the re­al voic­es, ex­pe­ri­ences, and unique needs that we heard di­rect­ly from the mBC com­mu­ni­ty — in­clud­ing the abil­i­ty to be present with fam­i­ly and friends, bal­ance work and life, and par­tic­i­pate in ac­tiv­i­ties that bring joy and im­proved health.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.